Editorial introductions
The changing landscape in metastatic castration-resistant prostate cancer
Urinary diversions
Side-effects associated with targeted therapies in renal cell carcinoma
The role of intermittent androgen suppression in biochemically recurrent or newly diagnosed metastatic prostate cancer
Managing hypercalcaemia and hypocalcaemia in cancer patients
Vitamin D in the cancer patient
The cost–effectiveness of external beam radiation therapy in bone metastases
Living with a health problem as a result of late effects
Pediatric oncology survivorship
Late effects care as an emerging clinical specialty in paediatric oncology
Developing international consensus for late effects screening and guidance
Transitional care of a childhood cancer survivor to adult services
Cost–effectiveness of follow-up services for childhood cancer survivors outside the cancer setting
Current World Literature